LABORATORIOS SAVAL

Select Your Country

Products Finder

VERTIFIN

Antivertigo

Betahistine dihydrochloride

Composition

Each tablet contains:
Betahistine dihydrochloride 16 mg
Excipient q.s.

Each tablet contains:
Betahistine dihydrochloride 24 mg
Excipient q.s.

Bioequivalence: This pharmaceutical product has demonstrated therapeutic equivalence.

Presentations

Package with 30 tablets

Indications

Pathological disorders due to microcirculatory deficit in the labyrinth: vertigo, tinnitus, hearing loss associated with Meniere's syndrome and correlated vertigo conditions.